⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABBV News
ABBVIE INC.
The Rise of 6 Emerging Therapies in a Critical Spinal Cord Injury Market Void | DelveInsight
globenewswire.com
ABBV
Throat Cancer Market Trends and Breakthroughs Through 2026-2030 & 2035 Driven by Precision Oncology
globenewswire.com
PFE
MRK
ABBV
INO
CHRS
Tumor Microenvironment Market to Reach Over $2.7 Billion by 2030 - Rising Demand for Personalized Oncology Therapies and Next-Gen Immunotherapies Driving the Industry
globenewswire.com
PFE
JNJ
MRK
ABBV
CHRS
AbbVie IBD Scholarship Program Marks 15 Years: Applications Open for 2026
globenewswire.com
ABBV
Glioblastoma Multiforme Market Intelligence Report 2026-2030 & 2035: Advanced Targeted Drugs Propel Industry Growth
globenewswire.com
PFE
ABBV
BMY
AZN
MRK
Gliosarcoma Market Intelligence Report 2026-2030 & 2035: Expansion of Molecular Testing and Increased Research Funding is Driving Industry Growth
globenewswire.com
NVCR
MRK
PFE
ABBV
Mission BioCapital Announces Opening of $4 Million 2026 Platinum Program Contest and 2025 Platinum Ticket Investments
prnewswire.com
ABBV
LLY
Pediatric Neuroblastoma Treatment Market Outlook 2026-2030 & 2035 - United Therapeutics Corporation, APEIRON Biologics, Pfizer, Bayer, and Amgen Dominate
globenewswire.com
UTHR
PFE
AMGN
JNJ
ABBV
MRK
BMY
MAC
FORE Biotherapeutics Receives Breakthrough Therapy Designation for Plixorafenib
businesswire.com
ABBV
MRK
DIA's LIFT Series Brings Startup Pitch Competitions, Innovation Programming to Global Annual Meeting
prnewswire.com
LLY
ABBV
MRNA